Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 60,730 shares at $8.93 ($534K) on 2023-06-02, disclosed to the SEC on 2023-06-05.
Scheduled sale ($534k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.58 | 25,000 | $215K | 40.2% |
| 2 | $8.93 | 17,865 | $160K | 29.9% |
| 3 | $8.93 | 17,865 | $160K | 29.9% |
| Total | $8.79 avg | 60,730 | $534K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |